A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats

A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats

Abstract Background Oclacitinib is a Janus kinase (JAK) 1 enzyme inhibitor and blocks JAK1-dependent cytokines and is used to control pruritus. Studies available in cats are very limited and as there is a potential role for oclacitinib in the control of pruritus in this specie, the aim of this study...

Full description

Bibliographic Details
Main Authors: Natália Lôres Lopes, Diefrey Ribeiro Campos, Marília Alves Machado, Mariana Silva Revoredo Alves, Manuela Silva Gomes de Souza, Cristiano Chaves Pessoa da Veiga, Alexandre Merlo, Fábio Barbour Scott, Julio Israel Fernandes
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Veterinary Research
Subjects:
Cats
Clinical effects
Feline
Oclacitinib
Pruritus
Safety
Online Access:http://link.springer.com/article/10.1186/s12917-019-1893-x

Internet

http://link.springer.com/article/10.1186/s12917-019-1893-x

Similar Items